Janux Therapeutics Inc (JANX)

SBC to Revenue

88.26%

Quarterly · Period ending:

JANX logo

JANX SBC to Revenue

Latest reported88.26%
JANX Quarterly SBC/Revenue (0.00% → 88.26%)
High-resolution chart · PNG

JANX sbc to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Janux Therapeutics Inc SBC to Revenue — Quarterly
Period endingSBC to Revenue
88.2634%
248.299%
0%
90.44%
0%
0%
0%
3,505.0114%
64.7072%
449.2812%
182.1617%
180.6913%
520.4352%
267.2363%
147.8032%
253.5025%
187.907%
249.0875%
182.1782%
221.3978%
264.9378%
32.3684%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.